Mixed-valence vanadium-doped mesoporous bioactive glass for treatment of tumor-associated bone defects

The scaffold induces UMR-106 cell death through a sustained, self-circulating redox mechanism involving mixed-valence vanadium and achieves dual therapeutic effects by simultaneously inhibiting osteosarcoma recurrence and promoting bone defect regeneration.